Concurrent use of bupropion with CYP2B6 inhibitors, nelfinavir, ritonavir and efavirenz: a case series.
Park-Wyllie
Laura Y
LY
Antoniou
Tony
T
D000328:Adult; D000368:Aged; D000480:Alkynes; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects* / Q000627:therapeutic use; D048588:Benzoxazines; D016642:Bupropion / Q000009:adverse effects* / Q000627:therapeutic use; D003521:Cyclopropanes; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D019888:Nelfinavir / Q000627:therapeutic use; D010078:Oxazines / Q000627:therapeutic use; D012189:Retrospective Studies; D019438:Ritonavir / Q000627:therapeutic use; D012640:Seizures / Q000139:chemically induced
D000480:Alkynes; D019380:Anti-HIV Agents; D018687:Antidepressive Agents, Second-Generation; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; D016642:Bupropion; D019888:Nelfinavir; C098320:efavirenz; D019438:Ritonavir